Brind.

Allegations surfaced regarding a potential monopoly on the cancer drug Pomalyst, involving Bristol Myers Squibb and The Cigna Group.

1 report, 0 independent Updated Jun 25

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Bristol-Myers Squibb The Cigna Group

Keep exploring

The entities involved

Bristol-Myers Squibb
American pharmaceutical company
- Bristol-Myers Squibb is developing innovative treatments and supporting Cyprus' national effort in haematology.Mon 13:45
- FDA gave tentative approval to Lupin for an alternative formulation of a Bristol-Myers Squibb drug, which Lupin plans to manufacture in Somerset.Mon 09:09
The Cigna Group
American health services organization

Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped

Jun 25Unknown outlet